Nitrogen monooxide en es it fr

Nitrogen monooxide Brand names, Nitrogen monooxide Analogs

Nitrogen monooxide Brand Names Mixture

  • Aldoril 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Aldoril 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 15 (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 25 (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide-25 Tab (Hydrochlorothiazide + Methyldopa)
  • Supres 150 Tab (Chlorothiazide + Methyldopa)
  • Supres 250 Tab (Chlorothiazide + Methyldopa)

Nitrogen monooxide Chemical_Formula


Nitrogen monooxide RX_link

Nitrogen monooxide fda sheet

Nitrogen_monooxide FDA

Nitrogen monooxide msds (material safety sheet)

Nitrogen_monooxide MSDS

Nitrogen monooxide Synthesis Reference

No information avaliable

Nitrogen monooxide Molecular Weight

30.0061 g/mol

Nitrogen monooxide Melting Point

-163.6 oC

Nitrogen monooxide H2O Solubility

9.49E+004 mg/L

Nitrogen monooxide State


Nitrogen monooxide LogP


Nitrogen monooxide Dosage Forms

Cream; Drops; Gas; Liquid; Lotion; Ointment; Powder; Tablet

Nitrogen monooxide Indication

For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure

Nitrogen monooxide Pharmacology

Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. In these states, pulmonary vascular resistance (PVR) is high, which results in hypoxemia secondary to right-to-left shunting of blood through the patent ductus arteriosus and foramen ovale. In neonates with PPHN, Nitric oxide improves oxygenation (as indicated by significant increases in PaO2). Nitric oxide appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better entilated areas of the lung, redistributing pulmonary blood flow away from lung regions with low ventilation/perfusion (V/Q) ratios toward regions with normal ratios.

Nitrogen monooxide Absorption

Nitric oxide is absorbed systemically after inhalation.

Nitrogen monooxide side effects and Toxicity

No information avaliable

Nitrogen monooxide Patient Information

No information avaliable

Nitrogen monooxide Organisms Affected

Humans and other mammals